Literature DB >> 8655148

Human chromosome 1 localization of the gene for a prostaglandin F2alpha receptor negative regulatory protein.

D J Orlicky1, R Berry, J M Sikela.   

Abstract

A protein that copurifies with the bovine prostaglandin F2alpha (FP) receptor has been isolated and the corresponding rat cDNA has been cloned. Transfection experiments suggest that this protein inhibits binding of [3H]prostaglandin F2alpha ([3H]PGF2alpha) to FP. Histologically, this protein (FP regulatory protein or FPRP) shows a distribution coinciding well with those cells and tissues that respond to PGF2alpha. A portion of the 3' untranslated region of the human homolog to fprp was subcloned, sequenced, and oligonucleotide primers chosen that allow polymerase chain reaction (PCR) amplification specifically of the human fprp sequence. These primers were then used in a PCR-based mapping-protocol. The human fprp gene was first socalized through human/rodent somatic cell hybrids to human chromosome 1 (100% concordance), and further through yeast artificial chromosome (YAC) pools to region 1p13.1-q21.3 (level 1 mapping). In view of the specific histologic localization of this negative regulator, possible pathological conditions are mentioned that may cosegrepate with this chromosomal region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655148     DOI: 10.1007/bf02281878

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Use of 3' untranslated sequences of human cDNAs for rapid chromosome assignment and conversion to STSs: implications for an expression map of the genome.

Authors:  A S Wilcox; A S Khan; J A Hopkins; J M Sikela
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Differential in vivo pulmonary degradation of prostaglandins E1, B1, and A1.

Authors:  R P Robertson
Journal:  Am J Physiol       Date:  1975-01

3.  Cloning, sequencing and proposed structure for a prostaglandin F2 alpha receptor regulatory protein.

Authors:  D J Orlicky; S K Nordeen
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1996-10       Impact factor: 4.006

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Prostaglandin F2 alpha receptors in the early bovine corpus luteum.

Authors:  M C Wiltbank; T F Shiao; D R Bergfelt; O J Ginther
Journal:  Biol Reprod       Date:  1995-01       Impact factor: 4.285

Review 6.  Molecular biology in the eicosanoid field.

Authors:  C D Funk
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1993

7.  Identification and purification of a bovine corpora luteal membrane glycoprotein with [3H]prostaglandin F2-alpha binding properties.

Authors:  D J Orlicky; G J Miller; R M Evans
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1990-09       Impact factor: 4.006

8.  Chromosomal localization of the human prostanoid receptor gene family.

Authors:  A M Duncan; L L Anderson; C D Funk; M Abramovitz; M Adam
Journal:  Genomics       Date:  1995-02-10       Impact factor: 5.736

Review 9.  Prostaglandin and thromboxane biosynthesis.

Authors:  W L Smith; L J Marnett; D L DeWitt
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

10.  Cloning and expression of a cDNA for the human prostanoid IP receptor.

Authors:  Y Boie; T H Rushmore; A Darmon-Goodwin; R Grygorczyk; D M Slipetz; K M Metters; M Abramovitz
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

View more
  1 in total

1.  Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins.

Authors:  Caroline Subra; David Grand; Karine Laulagnier; Alexandre Stella; Gérard Lambeau; Michael Paillasse; Philippe De Medina; Bernard Monsarrat; Bertrand Perret; Sandrine Silvente-Poirot; Marc Poirot; Michel Record
Journal:  J Lipid Res       Date:  2010-04-27       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.